Windlas Biotech has informed regarding intimation of completion of Buyback by Windlas Biotech in terms of the provisions of Securities & Exchange Board of India (Buy Back of Securities) Regulations, 2018 (Buyback Regulations) through Open Market Route.
The above information is a part of company’s filings submitted to BSE.